Anaveon
PrivateLast Round
Series B
Dec 16, 2021
Est. Valuation
$248.5M
Total Funding Raised
$155.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Anaveon is a biotechnology company that develops next-generation precision biologics designed to selectively modulate the immune system for the treatment of autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anaveon Comparables
Compare Anaveon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 83% | |
| Aulos Bioscience | 80% | |
| Medicenna Therapeutics Corp | 78% | |
Anaveon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 16, 2021 | ||||
| Series A | Feb 26, 2019 | ||||
| Grant | Dec 1, 2017 |
Key People
Founding team and executive leadership
Anaveon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| Forbion | Series B |
| Syncona | Series B, Series A |
| Pontifax Venture Capital | Series B |
| Pontifax Credit | Series B |
| TD Securities | Series B |
| Blue Owl Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Thaminda Ramanayake appointed as new Chief Executive Officer.
- Feb 26, 2019
$35M round led by Syncona.
Anaveon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anaveon's valuation, stock price, and market status.